SNY.NASDAQSanofi
13F-HR: Sanofi 13F Holdings — June 30, 2026
Institutional Holdings Report (13F)
Sanofi reported 10 holdings worth $534.0M for the period ended June 30, 2026.
Summary
- Sanofi reported 10 holdings worth $534.0M as of June 30, 2026.
- MeiraGTx Holdings plc — $164.8M (30.86%), 12,197,737 SH.
- Inhibrx Biosciences, Inc. — $109.7M (20.54%), 1,157,926 SH.
- Novavax — $64.8M (12.14%), 6,880,481 SH.
- AnaptysBio — $55.5M (10.39%), 821,917 SH.
- Odyssey Therapeutics Inc. — $37.3M (6.98%), 1,991,918 SH.
Top Holdings
Sanofi · 10 positions · $534.0M total · as of June 30, 2026
| Issuer | Value | % Port. | Shares |
|---|---|---|---|
| MeiraGTx Holdings plc | $164.8M | 30.86% | 12,197,737 |
| Inhibrx Biosciences, Inc. | $109.7M | 20.54% | 1,157,926 |
| Novavax | $64.8M | 12.14% | 6,880,481 |
| AnaptysBio | $55.5M | 10.39% | 821,917 |
| Odyssey Therapeutics Inc. | $37.3M | 6.98% | 1,991,918 |
| Agomab Therapeutics NV | $36.1M | 6.76% | 2,783,096 |
| MapLight Therapeutics Inc. | $32.7M | 6.12% | 912,041 |
| First Tracks Biotherapeutics Inc. | $16.5M | 3.1% | 821,917 |
| Immuneering Corp | $13.5M | 2.53% | 2,708,559 |
| Q32 Bio Inc. | $3.1M | 0.58% | 244,083 |
Keywords
13F, institutional holdings, Sanofi, MeiraGTx Holdings plc, Inhibrx Biosciences, Inc., Novavax, AnaptysBio, Odyssey Therapeutics Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.